Amoeba SA

As of December 31, 2024, Amoeba SA carries a market capitalization of 44.17M, placing it among publicly traded companies globally. Its enterprise value stands at 55.77M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Amoeba SA's next confirmed earnings release is scheduled for April 1, 2027.

As of December 31, 2024, Amoeba SA has 49.63M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Amoeba SA maintains a current ratio of 0.42, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, Amoeba SA's stock has declined approximately 72.27% over the past 52 weeks. The 50-day moving average sits at 0.50, while the 200-day moving average is 0.77.

As of December 31, 2024, Amoeba SA holds 458,938.00 in cash and equivalents against 12.07M in total debt, resulting in a net debt position of 11.10M. Total book value stands at -10.41M, with working capital of -3.02M providing operational flexibility.